1. Home
  2. FFA vs SPRC Comparison

FFA vs SPRC Comparison

Compare FFA & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Enhanced Equity Income Fund

FFA

First Trust Enhanced Equity Income Fund

HOLD

Current Price

$22.43

Market Cap

428.9M

Sector

Finance

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$4.78

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFA
SPRC
Founded
N/A
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.9M
3.3M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
FFA
SPRC
Price
$22.43
$4.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.0K
185.9K
Earning Date
01-01-0001
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.50
$0.46
52 Week High
$23.24
$15.79

Technical Indicators

Market Signals
Indicator
FFA
SPRC
Relative Strength Index (RSI) 52.71 35.45
Support Level $21.13 $3.28
Resistance Level $23.24 $4.85
Average True Range (ATR) 0.25 0.59
MACD 0.00 -0.43
Stochastic Oscillator 76.15 0.00

Price Performance

Historical Comparison
FFA
SPRC

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: